Much evidence has increased the scientific interest in the role of the Hv1 proton channel as an anti-tumoral therapeutic target, as they are present in a broad set of cancer types, contributing to the progression of the neoplastic process by enhancing the survival and the metabolism of tumoral cells, alkalinizing its cytosol (See section above). This evidence concerns the gene HVCN1 and cancer.